JGP Global Gestao de Recursos’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

JGP Global Gestao de Recursos’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,272	Closed	-$225K	–	85
2021 Q3	$225K	Buy	+1,272	New	+$205K	0.08%	68
2021 Q1	–	Sell	-2,380	Closed	-$523K	–	67
2020 Q4	$523K	Sell	2,380 -16	-0.7%	-$3.46K	1.97%	17
2020 Q3	$398K	Sell	2,396 -11	-0.5%	-$1.5K	0.22%	37
2020 Q2	$275K	Buy	+2,407	New	+$233K	0.16%	48
2020 Q1	–	Sell	-2,087	Closed	-$269K	–	68
2019 Q4	$269K	Buy	+2,087	New	+$201K	0.1%	56
2019 Q2	–	Sell	-3,296	Closed	-$242K	–	81
2019 Q1	$242K	Buy	+3,296	New	+$224K	0.09%	55

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JGP Global Gestao de Recursos's MRTX Position: Q4 2021 in Review

JGP Global Gestao de Recursos sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2021, closing a stake of 1,272 shares — an estimated $225K sold.

JGP Global Gestao de Recursos first reported a position in MRTX in Q1 2019 and held it in 6 quarters. The position peaked at $523K in Q4 2020. 260 funds tracked by Wall St. Rank hold MRTX as of Q4 2021.

JGP Global Gestao de Recursos reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
JGP Global Gestao de Recursos sold 1,272 Mirati Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $225K.
JGP Global Gestao de Recursos first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
JGP Global Gestao de Recursos's Mirati Therapeutics, Inc. Common Stock position peaked at $523K in Q4 2020.
260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2021.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2021, filed 3 Feb 2022.